ストックスクリーナーアプリを入手
262.28
0.85%
1.6397
Amgen Inc (AMGN) 最新ニュース
1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street - The Motley Fool
Piper Sandler Lowers Amgen (NASDAQ:AMGN) Price Target to $310.00 - MarketBeat
Amgen (NASDAQ:AMGN) Given "Overweight" Rating at Piper Sandler Companies - MarketBeat
Analyst Expectations For Amgen's Future - Benzinga
Amgen stock price formed a death cross: will it rebound in 2025? - MSN
Amgen (AMGN) Advances While Market Declines: Some Information for Investors - MSN
Land deal tops $10 million in development hot spot - The Business Journals
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Is Amgen Inc. (AMGN) the Best Pharma Dividend Stock to Buy In 2024? - Yahoo Finance
Amgen Plans To Expand N.C. Campus - Los Angeles Business Journal
Amgen plans $1B investment in North Carolina - AOL
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
Amgen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Amgen buys 22 acres near its New Albany facility - The Business Journals
Amgen Inc. stock rises Tuesday, still underperforms market - MarketWatch
Here's Why Amgen (AMGN) Gained But Lagged the Market Today - Yahoo Finance
Amgen Inc. stock rises Monday, still underperforms market - MarketWatch
Amgen, Lilly Sue HHS Over Clinics in Drug Discount Program - Bloomberg Law
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know - MSN
Cell Therapy Market Overall Study Report 2024-2031 | Amgen Inc., - openPR
Novo obesity data positive for Eli Lilly and Amgen, says UBS - Yahoo Finance
Amgen - Contract Pharma
Amgen Inc. stock rises Friday, still underperforms market - MarketWatch
What's Going On With Amgen Stock On Friday? - Benzinga
Amgen (AMGN) Rises Over 3% Amid Novo Nordisk Trial Results - GuruFocus.com
Amgen (NASDAQ:AMGN) Shares Gap UpTime to Buy? - MarketBeat
Principal Financial Group Inc. Increases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
[Amgen Inc. v. Sanofi] Oral Argument - C-SPAN
Amgen (NASDAQ:AMGN) Reaches New 1-Year LowTime to Sell? - MarketBeat
Amgen stock touches 52-week low at $257.77 amid market shifts By Investing.com - Investing.com South Africa
Amgen stock touches 52-week low at $257.77 amid market shifts - Investing.com Australia
Why Is Amgen Inc. (AMGN) Among the Best Dividend Stocks to Invest In? - Insider Monkey
Herceptin Biosimilar Market Future Business Opportunities - openPR
Amgen's SWOT analysis: stock poised for growth amid obesity market potential - Investing.com
Amgen Hit With $50M Infringement Verdict Over Leukemia Drug - Law360
Amgen Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Amgen hit with $50.3 mln US verdict in cancer drug patent lawsuit - Reuters.com
Amgen Owes Lindis $50 Million Patent Royalty Over Blincyto (1) - Bloomberg Law
Amgen (NASDAQ:AMGN) Stock Rating Lowered by StockNews.com - MarketBeat
Biologics Market to See Booming Growth 2024-2031 | AbbVie Inc., - openPR
Amgen (AMGN) Stock Moves -0.21%: What You Should Know - Yahoo Finance
Amgen Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Is Amgen Inc. (AMGN) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
KRAS Inhibitors Market Top Companies StudyAmgen, Boehringer - openPR
Viridian taking on Amgen in TED market - BioCentury
Viridian Continues Building Case For Veligrotug In TED - Citeline News & Insights
Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen - Yahoo! Voices
Amgen's SWOT analysis: obesity program drives stock outlook - Investing.com
How Much Would It Take To Earn $100 A Month From Amgen Stock - Yahoo Finance
Amgen's (NASDAQ:AMGN) investors will be pleased with their favorable 34% return over the last three years - Simply Wall St
Amgen's (NASDAQ:AMGN) Dividend Will Be Increased To $2.38 - Simply Wall St
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Franklin Resources Inc. - MarketBeat
World Investment Advisors LLC Raises Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. stock underperforms Friday when compared to competitors - MarketWatch
Dow's 112-point fall led by losses in NVIDIA Corp., Amgen shares - MarketWatch
Amgen to build $1B North Carolina pharmaceutical plant - Manufacturing Dive
Asset Advisors Investment Management LLC Boosts Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Synovus Financial Corp - MarketBeat
Virtu Financial LLC Takes Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1.09%
0.12%
大文字化:
|
ボリューム (24 時間):